Bhutan vs Portugal: The number of people with susceptibility test result for rifampicin
Bhutan
419
in 2021
Portugal
482
in 2021
Bhutan rank
83rd
Portugal rank
81st
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Portugal
How they compare
Portugal currently reports 482 against 419 in Bhutan, a difference of 63.
That makes Portugal's figure about 1.2 times Bhutan's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Portugal ahead.
Bhutan ranks 83rd and Portugal ranks 81st of 155 countries.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 400.33 | 625 | 224.67 | Portugal |
| 2020s | 426.5 | 460.5 | 34 | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Portugal?
- Portugal, at 482 against 419 in Bhutan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Portugal?
- 63, with Portugal ahead.
- How many years of comparable data are there for Bhutan and Portugal?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Portugal rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 83rd and Portugal ranks 81st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.